Clinical Outcome of Kidney Transplant Recipients with C1q-Binding De Novo Donor Specific Antibodies: A Single-Center Experience
S Marinaki, A Vittoraki, S Tsiakas, I Kofotolios… - Journal of Clinical …, 2023 - mdpi.com
Complement activation by HLA antibodies is a key component of immune-mediated graft
injury. We examined the clinical outcomes of kidney transplant recipients with complement …
injury. We examined the clinical outcomes of kidney transplant recipients with complement …
Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft …
M Gniewkiewicz, K Czerwinska, K Zielniok… - Journal of Clinical …, 2023 - mdpi.com
The post-transplant evolution of antihuman leukocyte antigen donor-specific antibodies (anti-
HLA DSAs) includes three clinical patterns: resolved preformed DSAs, persistent preformed …
HLA DSAs) includes three clinical patterns: resolved preformed DSAs, persistent preformed …